NORTCQUIMICA (NRTQ3) Main Indicators
Basic Data - NRTQ3
| Company | NORTCQUIMICA |
| Corporate Name | NORTEC QUÍMICA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Tradicional - BOVESPA |
| Activity | Química Fina. Ciências da Vida. fabricantes de Insumos Farmacêuticos Ativos - matéria-prima para a Indústria Farmacêutica |
| Share | NRTQ3 |
| Quote Date | NA |
| Share Type | ON |
| Last Closing | NA |
| Quotation Factor | NA |
| Financial Volume | NA |
| Last Statement | ITR - 09/30/2024 |
| Sector | Saúde |
| Subsector | Medicamentos e Outros Produtos |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | - |
| Updated 11/21/2024 | |
Relative Prices - NRTQ3
| Price/Earnings | 0.00 |
| Price/SBV | 0.00 |
| Price/Net Sales | 0.00 |
| Price/CFO | 0.00 |
| Price/FCF | 0.00 |
| Price/Total Assets | 0.00 |
| Price/EBIT | 0.00 |
| Price/Working Capital | 0.00 |
| Price/NCAV | 0.00 |
| EV/EBIT | NA |
| EV/EBITDA | NA |
| EV/Net Sales | NA |
| EV/CFO | NA |
| EV/FCF | NA |
| EV/Total Assets | NA |
| Company Market Cap | NA |
| Enterprise Value | NA |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 0.00 |
| Share Price Date | //0 |
| Dividend Yield | 0.00% |
| Updated 11/21/2024 | |
Income Statement - NRTQ3
| Net Revenue | R$ 217.54 M |
| Gross Result | R$ 51.58 M |
| EBIT | R$ 12.69 M |
| Depreciation and Amortization | - R$ 12.95 M |
| EBITDA | R$ 25.64 M |
| Net Profit | R$ 9.57 M |
| Net Profit/Share | R$ 0.81 |
| Updated 11/12/2024 | |
| Net Revenue | R$ 67.09 M |
| Gross Result | R$ 20.93 M |
| EBIT | R$ 10.18 M |
| Depreciation and Amortization | - R$ 2.96 M |
| EBITDA | R$ 13.14 M |
| Net Profit | R$ 6.29 M |
| Profit/Share | R$ 0.53 |
| Updated 11/12/2024 | |
Price and Volume Behavior - NRTQ3
There are no quotes for this ticker.
Returns and Margins - NRTQ3
| Return on Initial Tangible Capital | 3.33% |
| Return on Initial Invested Capital | 3.36% |
| Pre-Tax Return on Initial Tangible Capital | 5.05% |
| Pre-Tax Return on Initial Invested Capital | 5.09% |
| Return on Initial Shareholder´s Equity | 4.04% |
| Return on Initial Asset | 2.87% |
| Gross Margin | 23.71% |
| Net Margin | 4.40% |
| EBIT Margin | 5.83% |
| EBITDA Margin | 11.79% |
| Initial Asset Turnover | 0.65 |
| Financial Leverage | 1.66 |
| Liabilities/Net Worth | 0.66 |
| Net Debt/EBITDA | 3.14 |
| Updated 11/12/2024 | |
Balance Sheet - NRTQ3
| Cash and Cash Equivalents | R$ 27.97 M |
| Total Assets | R$ 395.05 M |
| Short-Term Debt | R$ 7.23 M |
| Long-Term Debt | R$ 101.24 M |
| Gross Debt | R$ 108.47 M |
| Net Debt | R$ 80.50 M |
| Shareholder´s Equity | R$ 238.40 M |
| Share Book Value | R$ 20.07 |
| Common Shares | 11,759,000 |
| Preferred Shares | 119,000 |
| Total | 11,878,000 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 11,759,000 |
| Preferred Shares (Except Treasury) | 119,000 |
| Total (Except Treasury) | 11,878,000 |
| Updated 11/12/2024 | |
Cash Flow - NRTQ3
| Operating Cash Flow | R$ 4.06 M |
| Cash Flow from Investments | - R$ 23.33 M |
| Financing Cash Flow | - R$ 2.02 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 21.30 M |
| Updated 11/12/2024 | |
| Operating Cash Flow | - R$ 1.66 M |
| Cash Flow from Investments | - R$ 3.60 M |
| Financing Cash Flow | R$ 4.13 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 1.13 M |
| Updated 11/12/2024 | |
Experimental - NRTQ3
| CAPEX 3 months | - R$ 6.23 M |
| Free Cash Flow 3 months | - R$ 7.89 M |
| CAPEX 12 months | - R$ 25.88 M |
| Free Cash Flow 12 months | - R$ 21.82 M |
| Updated 11/12/2024 | |
Quote Chart - NRTQ3
There are no quotes for this ticker.